Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
02/2004
02/18/2004EP0728012B1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
02/17/2004US6693081 Bone stimulating factor
02/12/2004WO2004013160A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
02/12/2004US20040029221 Identification and isolation of novel DNA and the recombinant production of novel polypeptides; for detecting the presence of tumors in mammals
02/12/2004US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/12/2004US20040029174 End selection in directed evolution
02/12/2004US20040029115 Labeling a terminal monomer and scanning to determine the position; can analyze hundreds of macromolecules simultaneously
02/12/2004DE10230210A1 Zusammensetzung und Verfahren zur Stabilisierung von Biomolekülen The composition and method of stabilizing biomolecules
02/12/2004CA2495478A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
02/11/2004EP1176987B1 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
02/11/2004EP0888452B1 Human cyr61, an extracellular matrix signalling molecule
02/11/2004CN1137899C 17,21-ester substituted 1,4-diene-3-keto-9,11-epoxy-steroid compound
02/11/2004CN1137722C Establishment of TONIC ovarian estrogen secretion for extended therapeutic regimens
02/05/2004WO2004010939A2 Methods of using non-human animal apoliprotein a-i protein
02/05/2004WO2003037172A3 Endothelial-cell binding peptides for diagnosis and therapy
02/05/2004US20040023414 Self-assembling peptide surfaces for cell patterning and interactions
02/05/2004US20040023366 Surface for the immobilization of ligands
02/05/2004US20040023256 Translation profiling
02/05/2004CA2833718A1 Biomimetic membranes
02/05/2004CA2727782A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase
02/05/2004CA2494098A1 Methods of using non-human animal apoliprotein a-i protein
02/04/2004EP1385859A2 Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
02/04/2004EP1107998B1 Method for the preparation of polyamide chains of precise length, their conjugates with proteins
02/03/2004US6685957 Preparation of fibrous polymer implant containing bioactive agents using wet spinning technique
01/2004
01/29/2004US20040018618 Genetic engineering; hybrid proteins; gene expression; human gene therapy
01/29/2004US20040018601 Sequestering, accumulation; immobilized lipid
01/29/2004US20040018543 Incubation; controlling temperature and pH
01/28/2004EP1384999A1 Bacteriotoxin adsorbents and method of screening the same
01/28/2004EP1384488A2 Method and kit for imaging organs and tissues, using labelled antibodies
01/28/2004EP1383922A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
01/22/2004WO2004007679A2 Dendritic cell pontentiation
01/22/2004WO2004007661A2 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides
01/22/2004WO2004006951A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors
01/22/2004WO2004006756A2 THERAPIES FOR RENAL FAILURE USING INTERFERON-β
01/22/2004US20040014242 An insoluble carrier having primary amino groups can be used as the carrier for absorptive immobilizations of a protein containing cysteine group, via ionic interection, then cyanating sulfhydryl group of cysteine with a cyanating agent
01/22/2004US20040014207 Dendritic cell potentiation
01/22/2004US20040014189 Direct encapsulation of biomacromolecules in surfactant templated mesoporous and nanoporous materials
01/22/2004US20040014186 Preparing thin film composed of silicon and duplicated amino acid sequences; biomineralization; electronics and photonics
01/22/2004DE10230223A1 Mikropartikel mit CD28-spezifischen monoklonalen Antikörpern Microparticles with CD28-specific monoclonal antibodies
01/22/2004CA2800113A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors
01/22/2004CA2492649A1 Therapies for renal failure using interferon-.beta.
01/22/2004CA2487378A1 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides
01/20/2004US6680171 Drug screening, genetic engineering
01/15/2004WO2004005477A2 Protein microarrays on mirrored surfaces for performing proteomic analyses
01/15/2004WO2004005319A2 Microarrays on mirrored substrates for performing proteomic analyses
01/15/2004WO2004004768A1 Microparticle with cd28-specific monoclonal antibodies
01/15/2004WO2004004455A2 Composition and method for stabilising biomolecules
01/15/2004US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy
01/15/2004US20040009548 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
01/15/2004US20040009547 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
01/15/2004CA2491691A1 Protein microarrays on mirrored surfaces for performing proteomic analyses
01/15/2004CA2491618A1 Microarrays on mirrored substrates for performing proteomic analyses
01/14/2004EP1379881A2 Method for determining the substrate specificity of an enzymatic activity and a device therefor
01/14/2004EP1379650A2 Preferred segments of neural thread protein and methods of using the same
01/14/2004EP1379644A2 Protein analysis by means of immobilized arrays of antigens or antibodies
01/14/2004EP1379545A2 Method for producing stable, regeneratable antibody arrays
01/08/2004WO2004002431A2 Humanized anti-lymphotoyin beta receptor antibodies
01/08/2004CA2491480A1 Humanized anti-lymphotoxin beta receptor antibodies
01/07/2004EP1377830A2 Arrays for determining binding of biomolecules
01/07/2004EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy
01/07/2004EP1377306A1 Serum albumin binding moieties
01/07/2004EP1377275A2 Vaccine for modulating between t1 and t2 immune responses
01/02/2004EP1375519A2 Method for affecting cellular function using antibodies
01/02/2004EP1373301A2 Reducing the immunogenicity of fusion proteins
01/02/2004EP1372686A4 Methods and compositions for peptide synthesis
01/02/2004EP1372686A2 Methods and compositions for peptide synthesis
01/01/2004US20040003418 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
12/2003
12/31/2003WO2003055916A3 Adiponectin fragments and conjugates
12/31/2003WO2002066984A3 Arrays for determining binding of biomolecules
12/30/2003US6670181 Compositions and methods for treating viral infections
12/25/2003US20030235853 Solid phase synthesis; for drug screening
12/24/2003WO2003106487A1 Immunogenic conjugates
12/24/2003CA2489724A1 Immunogenic conjugates
12/18/2003WO2003040726A3 Screening for hepatitis c virus entry inhibitors
12/18/2003WO2002092788A3 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof
12/18/2003US20030232745 Uses of DC-sign and DC-Signr for inhibiting hepatitis C virus infection
12/18/2003US20030232333 Cleaving single-stranded nucleic acid sequences at a desired location, using a restriction endonuclease that is active at the chosen temperature
12/16/2003US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
12/11/2003WO2003038033A3 Protein and peptide nanoarrays
12/11/2003WO2003037172A9 Endothelial-cell binding peptides for diagnosis and therapy
12/11/2003WO2003033672A3 Nr3b nmda receptor subunit compositions and related methods
12/11/2003US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors
12/11/2003US20030228274 Immobilization of polypeptide with polyamide-polyether
12/10/2003EP1368050A2 Virus derived antimicrobial peptides
12/09/2003US6660533 Attaching proteins to the surface of silica supports via immobilization; medical diagnosis
12/09/2003US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer
12/04/2003WO2003099855A1 Device for the presentation of peptides or proteins, method for the preparation and use thereof
12/04/2003WO2003099465A1 Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers
12/04/2003WO2003045980A3 Glycopeptide remodeling using amidases
12/04/2003US20030224494 Polyhydroxyalkanoate-containing structure and manufacturing method thereof
12/04/2003US20030224453 Structural models for cytoplasmic domains of transmembrane receptors
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/03/2003EP1367121A2 Process for immobilizing polypeptides via the carboxyl group of the C-terminus
12/02/2003US6656876 Squaric acid activated carrier usable for immobilization of compounds containing amine groups
12/02/2003US6656712 Method for immobilizing and/or crystallizing biological macromolecules on carbon nanotubes and uses
12/02/2003US6656468 Such as botulinus antitoxin orally
11/2003
11/27/2003WO2003098214A1 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
11/27/2003WO2003097699A1 Immobilization of glycoproteins
11/27/2003WO2003097672A1 Method for controlling protein
11/27/2003WO2003064604A3 Translation profiling
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 107